Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DemeRx
AddedFeb 16, 2024
UpdatedJun 18, 2026
DemeRx

DemeRx

Angel

DemeRx, a Miami-based company, pioneers treatments for drug addiction in chronic pain patients since 2010.

HQ
Miami, FL, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

DemeRx, founded in 2010 and based in Miami, Florida, is dedicated to developing non-addictive treatments for drug addiction, particularly targeting patients suffering from chronic pain. The company's core mission is to provide innovative, non-addictive drug products that address substance use disorders. DemeRx is currently advancing two molecules through clinical stages, aiming to make significant impacts in billion-dollar markets related to drug and alcohol abuse treatment.

Notable figures associated with DemeRx include its team of experienced researchers and clinicians who drive the company's pioneering efforts. The company has garnered attention from key investors in the healthcare sector, supporting its mission to revolutionize addiction treatment. DemeRx's achievements in advancing its product candidates through clinical trials underscore its potential to significantly impact the field of substance use disorder treatment, offering hope for more effective and safer therapies.

DemeRx - Similar Companies

Phoenix PharmaLabs logo

Phoenix PharmaLabs

Embera Neurotherapeutics logo

Embera Neurotherapeutics

emberaneuro.com

DMK Pharmaceuticals logo

DMK Pharmaceuticals

DeuteRx logo

DeuteRx

deuterx.com

Tremeau Pharmaceuticals logo

Tremeau Pharmaceuticals

Encepheal Therapeutics logo

Encepheal Therapeutics

Microneb logo

Microneb

microneb.com

Neumedics logo

Neumedics

Pacira BioSciences logo

Pacira BioSciences

pacira.com

Aether Therapeutics logo

Aether Therapeutics

Adrx logo

Adrx

adrxpharma.com

Dmed logo

Dmed

dmedglobal.com

Demetrix logo

Demetrix

demetrix.com

Royal Emerald Pharmaceuticals logo

Royal Emerald Pharmaceuticals

royalemeraldrx.com

Latigo Biotherapeutics logo

Latigo Biotherapeutics

latigobio.com

DemeRx - Quick Facts

Who are DemeRx's competitors?

Companies similar to DemeRx include Phoenix PharmaLabs, Embera Neurotherapeutics, DMK Pharmaceuticals and DeuteRx.

When was DemeRx founded?

DemeRx was founded in 2010.

Where is DemeRx's headquarters located?

DemeRx's headquarters is located in Miami, FL, US.

When was DemeRx's last funding round?

DemeRx's most recent funding round was for $289.6k (USD) in May 2015.

How much has DemeRx raised to-date?

As of May 8, 2015, DemeRx has raised a total of $489.6k (USD).

How many employees does DemeRx have?

DemeRx has 11 employees as of Feb 5, 2024.

DemeRx - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Treatments
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research